US Patent Issued to University of Louisville Research Foundation, Georgia Tech Research on July 7 for "FasL-engineered biomaterials with immunomodulatory function" (Kentucky, Georgia Inventors)

ALEXANDRIA, Va., July 7 -- United States Patent no. 12,673,073, issued on July 7, was assigned to University of Louisville Research Foundation Inc. (Louisville, Ky.) and Georgia Tech Research Corp. (Atlanta).

"FasL-engineered biomaterials with immunomodulatory function" was invented by Haval Shirwan (Louisville, Ky.), Andres J. Garcia (Atlanta), Esma S. Yolcu (Louisville, Ky.), Hong Zhao (Louisville, Ky.) and Devon Headen (Atlanta).

According to the abstract* released by the U.S. Patent & Trademark Office: "Described herein are FasL-engineered biomaterials, as well as methods of making and using such FasL-engineered biomaterials, such as for immunomodulation, such as for inducing immunosuppression and specific immune tolerance, such as fo...